These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

958 related articles for article (PubMed ID: 15765097)

  • 81. Analysis of Histone Modifications from Tryptic Peptides of Deuteroacetylated Isoforms.
    Hersman E; Nelson DM; Griffith WP; Jelinek C; Cotter RJ
    Int J Mass Spectrom; 2012 Feb; 312():5-16. PubMed ID: 22389584
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Metabolic Ink Lactate Modulates Epigenomic Landscape: A Concerted Role of Pro-tumor Microenvironment and Macroenvironment During Carcinogenesis.
    Sharma NK; Pal JK
    Curr Mol Med; 2021; 21(3):177-181. PubMed ID: 32436828
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Chromatin modifications and their function.
    Kouzarides T
    Cell; 2007 Feb; 128(4):693-705. PubMed ID: 17320507
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.
    Elsheikh SE; Green AR; Rakha EA; Powe DG; Ahmed RA; Collins HM; Soria D; Garibaldi JM; Paish CE; Ammar AA; Grainge MJ; Ball GR; Abdelghany MK; Martinez-Pomares L; Heery DM; Ellis IO
    Cancer Res; 2009 May; 69(9):3802-9. PubMed ID: 19366799
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Global histone modification patterns predict risk of prostate cancer recurrence.
    Seligson DB; Horvath S; Shi T; Yu H; Tze S; Grunstein M; Kurdistani SK
    Nature; 2005 Jun; 435(7046):1262-6. PubMed ID: 15988529
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Histone H4-K16 acetylation controls chromatin structure and protein interactions.
    Shogren-Knaak M; Ishii H; Sun JM; Pazin MJ; Davie JR; Peterson CL
    Science; 2006 Feb; 311(5762):844-7. PubMed ID: 16469925
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Histone modifications and cancer.
    Sawan C; Herceg Z
    Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Combinatorial patterns of histone acetylations and methylations in the human genome.
    Wang Z; Zang C; Rosenfeld JA; Schones DE; Barski A; Cuddapah S; Cui K; Roh TY; Peng W; Zhang MQ; Zhao K
    Nat Genet; 2008 Jul; 40(7):897-903. PubMed ID: 18552846
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The epigenomics of cancer.
    Jones PA; Baylin SB
    Cell; 2007 Feb; 128(4):683-92. PubMed ID: 17320506
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Histone H4 lysine 20 methylation: key player in epigenetic regulation of genomic integrity.
    Jørgensen S; Schotta G; Sørensen CS
    Nucleic Acids Res; 2013 Mar; 41(5):2797-806. PubMed ID: 23345616
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Hypomethylation distinguishes genes of some human cancers from their normal counterparts.
    Feinberg AP; Vogelstein B
    Nature; 1983 Jan; 301(5895):89-92. PubMed ID: 6185846
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Global levels of histone modifications predict prognosis in different cancers.
    Seligson DB; Horvath S; McBrian MA; Mah V; Yu H; Tze S; Wang Q; Chia D; Goodglick L; Kurdistani SK
    Am J Pathol; 2009 May; 174(5):1619-28. PubMed ID: 19349354
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cancer epigenomics: DNA methylomes and histone-modification maps.
    Esteller M
    Nat Rev Genet; 2007 Apr; 8(4):286-98. PubMed ID: 17339880
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Epigenetic differences arise during the lifetime of monozygotic twins.
    Fraga MF; Ballestar E; Paz MF; Ropero S; Setien F; Ballestar ML; Heine-Suñer D; Cigudosa JC; Urioste M; Benitez J; Boix-Chornet M; Sanchez-Aguilera A; Ling C; Carlsson E; Poulsen P; Vaag A; Stephan Z; Spector TD; Wu YZ; Plass C; Esteller M
    Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10604-9. PubMed ID: 16009939
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity.
    Yokoyama Y; Matsumoto A; Hieda M; Shinchi Y; Ogihara E; Hamada M; Nishioka Y; Kimura H; Yoshidome K; Tsujimoto M; Matsuura N
    Breast Cancer Res; 2014 Jun; 16(3):R66. PubMed ID: 24953066
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The role of histone deacetylases (HDACs) in human cancer.
    Ropero S; Esteller M
    Mol Oncol; 2007 Jun; 1(1):19-25. PubMed ID: 19383284
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Epigenetics in cancer.
    Esteller M
    N Engl J Med; 2008 Mar; 358(11):1148-59. PubMed ID: 18337604
    [No Abstract]   [Full Text] [Related]  

  • 98. Increased expression of histone deacetylase 2 is found in human gastric cancer.
    Song J; Noh JH; Lee JH; Eun JW; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Nam SW
    APMIS; 2005 Apr; 113(4):264-8. PubMed ID: 15865607
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Genome-wide distribution of histone H4 Lysine 16 acetylation sites and their relationship to gene expression.
    Horikoshi N; Kumar P; Sharma GG; Chen M; Hunt CR; Westover K; Chowdhury S; Pandita TK
    Genome Integr; 2013 Apr; 4(1):3. PubMed ID: 23587301
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Anticancer activities of histone deacetylase inhibitors.
    Bolden JE; Peart MJ; Johnstone RW
    Nat Rev Drug Discov; 2006 Sep; 5(9):769-84. PubMed ID: 16955068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.